I didn't realise that peramavir wan't effective against the mutation. I've seen IV relenza mentioned a long time back.
Do you think GSK may take up the ROW rights to LANI? They seem to be promoting Relenza and their vaccines much more so in recent years and they compliment each other.
- Forums
- ASX - By Stock
- BTA
- glaxosmithkline update: influenza a (h1n1)
glaxosmithkline update: influenza a (h1n1), page-9
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online